Aurinia Pharmaceuticals stock climbs on insider buying

 

• Aurinia Pharmaceuticals (NASDAQ:AUPH) shares rose about 7% in morning trade after its Director, Kevin Tang, disclosed purchase of company stocks.
• Tang disclosed three transactions with the SEC, buying 399,280 shares for a price of $7.85 per share, 452,682 shares for a price of $8.01 per share and 748,038 shares for a price of $7.96 per share.
• In total, the shares bought were of a value of approximately $12.7M.
• Tang now holds about 10M shares of the company.

https://www.msn.com/en-us/money/markets/aurinia-pharmaceuticals-stock-climbs-on-insider-buying/ar-AA1AjddS?ocid=finance-verthp-feeds